Polynovo Limited
ASX: PNV
PolyNovo powers ahead with robust global growth, record revenues, and breakthrough innovation.
(Source: TradingView) 3-Month Performance Profile of PNV compared to the S&P/ASX 200 (XJO).
PolyNovo delivered a strong first-half performance in FY25, underpinned by sustained global demand for NovoSorb BTM, which is now used in over 46 countries with more than 67,000 pati
🔒
Subscribers only
Sign in with your subscriber account or subscribe to access this research report.
Required subscription
Daily Digest
A$200.00
Already a subscriber?
Sign in to read this report.
Required subscription
Daily Digest
Stay informed with expert daily ASX research covering four carefully selected stocks, complete with market insights, risk ratings, and clear Buy, Hold, or Sell general guidance—delivered before the market opens each trading day.
- ✓ Four Expert-Selected ASX Stocks Daily
- ✓ Weekday Pre-Market Delivery
- ✓ In-Depth Research & Analysis
- ✓ Access to All Previous Reports
A$200.00/ 12 months
Risk:Medium
Subscribe Now →
